Literature DB >> 23357831

Single-molecule approaches to prion protein misfolding.

Hao Yu1, Derek R Dee, Michael T Woodside.   

Abstract

The structural conversion of the prion protein PrP into a transmissible, misfolded form is the central element of prion disease, yet there is little consensus as to how it occurs. Key aspects of conversion into the diseased state remain unsettled, from details about the earliest stages of misfolding such as the involvement of partially- or fully-unfolded intermediates to the structure of the infectious state. Part of the difficulty in understanding the structural conversion arises from the complexity of the underlying energy landscapes. Single molecule methods provide a powerful tool for probing complex folding pathways as in prion misfolding, because they allow rare and transient events to be observed directly. We discuss recent work applying single-molecule probes to study misfolding in prion proteins, and what it has revealed about the folding dynamics of PrP that may underlie its unique behavior. We also discuss single-molecule studies probing the interactions that stabilize non-native structures within aggregates, pointing the way to future work that may help identify the microscopic events triggering pathogenic conversion. Although single-molecule approaches to misfolding are relatively young, they have a promising future in prion science.

Entities:  

Keywords:  aggregation; atomic force microscopy; fluorescence spectroscopy; force spectroscopy; oligomerization; optical tweezers; protein misfolding; single-molecule

Mesh:

Substances:

Year:  2013        PMID: 23357831      PMCID: PMC3609121          DOI: 10.4161/pri.23303

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  54 in total

1.  Signal-pair correlation analysis of single-molecule trajectories.

Authors:  Armin Hoffmann; Michael T Woodside
Journal:  Angew Chem Int Ed Engl       Date:  2011-11-04       Impact factor: 15.336

2.  Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.

Authors:  Trent C Bjorndahl; Guo-Ping Zhou; Xuehui Liu; Rolando Perez-Pineiro; Valentyna Semenchenko; Fozia Saleem; Sandipta Acharya; Adina Bujold; Constance A Sobsey; David S Wishart
Journal:  Biochemistry       Date:  2011-01-27       Impact factor: 3.162

Review 3.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Folding kinetics of the human prion protein probed by temperature jump.

Authors:  Tanya Hart; Laszlo L P Hosszu; Clare R Trevitt; Graham S Jackson; Jonathan P Waltho; John Collinge; Anthony R Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

5.  Unfolded-state structure and dynamics influence the fibril formation of human prion protein.

Authors:  Christian Gerum; Robert Silvers; Julia Wirmer-Bartoschek; Harald Schwalbe
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 6.  High-resolution structure of infectious prion protein: the final frontier.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Nat Struct Mol Biol       Date:  2012-04-04       Impact factor: 15.369

7.  Highly neurotoxic monomeric α-helical prion protein.

Authors:  Minghai Zhou; Gregory Ottenberg; Gian Franco Sferrazza; Corinne Ida Lasmézas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Optical trapping with high forces reveals unexpected behaviors of prion fibrils.

Authors:  Jijun Dong; Carlos E Castro; Mary C Boyce; Matthew J Lang; Susan Lindquist
Journal:  Nat Struct Mol Biol       Date:  2010-11-28       Impact factor: 15.369

10.  Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange.

Authors:  Vytautas Smirnovas; Gerald S Baron; Danielle K Offerdahl; Gregory J Raymond; Byron Caughey; Witold K Surewicz
Journal:  Nat Struct Mol Biol       Date:  2011-03-27       Impact factor: 15.369

View more
  7 in total

1.  Protein misfolding occurs by slow diffusion across multiple barriers in a rough energy landscape.

Authors:  Hao Yu; Derek R Dee; Xia Liu; Angela M Brigley; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-24       Impact factor: 11.205

2.  Comparing the energy landscapes for native folding and aggregation of PrP.

Authors:  Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

3.  Probing of Amyloid Aβ (14-23) Trimers by Single-Molecule Force Spectroscopy.

Authors:  Sibaprasad Maity; Yuri L Lyubchenko
Journal:  Jacobs J Mol Transl Med       Date:  2015-06-09

4.  Unfolded and intermediate states of PrP play a key role in the mechanism of action of an antiprion chaperone.

Authors:  Rafayel Petrosyan; Shubhadeep Patra; Negar Rezajooei; Craig R Garen; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

5.  Knotting and unknotting of a protein in single molecule experiments.

Authors:  Fabian Ziegler; Nicole C H Lim; Soumit Sankar Mandal; Benjamin Pelz; Wei-Ping Ng; Michael Schlierf; Sophie E Jackson; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-23       Impact factor: 11.205

6.  Diverse metastable structures formed by small oligomers of α-synuclein probed by force spectroscopy.

Authors:  Krishna Neupane; Allison Solanki; Iveta Sosova; Miro Belov; Michael T Woodside
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

7.  Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein.

Authors:  Amar Nath Gupta; Krishna Neupane; Negar Rezajooei; Leonardo M Cortez; Valerie L Sim; Michael T Woodside
Journal:  Nat Commun       Date:  2016-06-27       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.